Alberta Investment Management Corp Exelixis, Inc. Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

A detailed history of Alberta Investment Management Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Alberta Investment Management Corp holds 100,000 shares of EXEL stock, worth $3.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

100,000

Previous 79,000 26.58%

Holding current value

$3.56 Million

Previous $1.78 Million 46.2%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$21.96 - $27.6 $461,160 - $579,600	21,000 Added 26.58%	100,000 $2.6 Million
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $545,112 - $635,964	26,800 Added 51.34%	79,000 $1.78 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $6 Million - $7.17 Million	-315,094 Reduced 85.79%	52,200 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $341,596 - $385,024	-18,800 Reduced 4.87%	367,294 $7.02 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $2.13 Million - $2.53 Million	130,525 Added 51.07%	386,094 $7.49 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $1.14 Million - $1.33 Million	76,244 Added 42.52%	255,569 $4.1 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $49,705 - $70,595	3,170 Added 1.8%	179,325 $2.81 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $1.27 Million - $1.69 Million	72,864 Added 70.54%	176,155 $3.67 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $1.76 Million - $2.34 Million	103,291 New	103,291 $2.34 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $735,600 - $992,000	-40,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$16.46 - $27.42 $658,400 - $1.1 Million	40,000 New	40,000 $950,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $640,920 - $809,652	-32,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $290,745 - $464,340	21,300 Added 186.84%	32,700 $643,000
Q3 2018 Nov 16, 2018	SELL	$15.87 - $22.4 $185,679 - $262,079	-11,700 Reduced 50.65%	11,400 $202,000
Q2 2018 Aug 15, 2018	BUY	$18.56 - $22.45 $428,735 - $518,595	23,100 New	23,100 $497,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Exelixis, Inc. Transaction History